hydroxychloroquine has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 7 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pregnancy seems to increase the risk of thrombotic thrombocytopenic purpura (TTP) relapses and make the TTP more severe in any of the pregnancy trimesters, or even during the postpartum period." | 1.62 | A COVID-19 pregnant patient with thrombotic thrombocytopenic purpura: a case report. ( Afrooz, N; Aminimoghaddam, S; Mahmoudzadeh, F; Motaghi Nejad, O; Nasiri, S, 2021) |
| "We report a case of acquired thrombotic thrombocytopenic purpura (TTP) in a 34-year old patient with a prior diagnosis of systemic lupus erythematosis (SLE) who was recently started on hydroxychloroquine." | 1.37 | Acquired thrombotic thrombocytopenic purpura: puzzles, curiosities and conundrums. ( Mar, N; Mendoza Ladd, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Arıkan, F | 1 |
| Yıldız, Y | 1 |
| Ercan, T | 1 |
| Oruç, Ö | 1 |
| Akçay, S | 1 |
| Yılmaz, F | 1 |
| Toptaş, T | 1 |
| Tuğlular, T | 1 |
| Sookaromdee, P | 1 |
| Wiwanitkit, V | 1 |
| Mir, TH | 1 |
| Aminimoghaddam, S | 1 |
| Afrooz, N | 1 |
| Nasiri, S | 1 |
| Motaghi Nejad, O | 1 |
| Mahmoudzadeh, F | 1 |
| Changcharoen, B | 1 |
| Bolger, DT | 1 |
| González, NS | 1 |
| Lorenzo, N | 1 |
| Parodis, Y | 1 |
| Ortiz, MBA | 1 |
| Kechida, M | 1 |
| Perez, JCR | 1 |
| Mar, N | 1 |
| Mendoza Ladd, A | 1 |
7 other studies available for hydroxychloroquine and Congenital Thrombotic Thrombocytopenic Purpura
| Article | Year |
|---|---|
Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura
Topics: ADAMTS13 Protein; Aged; Angiography; COVID-19; Humans; Hydroxychloroquine; Male; Plasmapheresis; Pul | 2020 |
Hydroxychloroquine, TTP, COVID-19, and SLE
Topics: COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Purpura, Thrombo | 2021 |
Immune Thrombotic Thrombocytopenic Purpura in a Patient with Suspected COVID-19: Hydroxychloroquine Culprit or Just Happenstance?
Topics: ADAMTS13 Protein; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Purpura, Thrombotic Thrombocy | 2021 |
A COVID-19 pregnant patient with thrombotic thrombocytopenic purpura: a case report.
Topics: Acute Kidney Injury; Amphetamine-Related Disorders; Antiviral Agents; COVID-19; Drug Combinations; E | 2021 |
Thrombotic thrombocytopenic purpura as an initial presentation of systemic lupus erythematosus with acquired ADAMTS 13 antibody.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Anemia, Hemolytic; Autoantibodies; Fatigue; Female; Headache | 2015 |
Thrombotic thrombocytopenic purpura in a new onset lupus patient?
Topics: Adult; Anemia, Hemolytic; Autoantibodies; Blood Platelets; Codeine; Cyclophosphamide; Female; Humans | 2017 |
Acquired thrombotic thrombocytopenic purpura: puzzles, curiosities and conundrums.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Antirheumatic Agents; Autoantibodies; Humans; Hydroxychloroq | 2011 |